This inventor holds 1 USPTO granted patent. Top assignee: The State University of New York. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: Adela Bonoiu: Innovator in RNA Interference Technology
Introduction
Adela Bonoiu is a prominent inventor based in North Tonawanda, NY (US). She has made significant contributions to the field of biotechnology, particularly in the area of RNA interference (RNAi). Her innovative work focuses on methods that utilize gold nanorods for gene expression inhibition.
Latest Patents
Adela Bonoiu holds a patent for a method of using gold nanorods-siRNA complexes. This patent describes methods and compositions for inhibiting the expression of one or more target genes. The compositions consist of RNA polynucleotides that can inhibit gene expression via RNA interference, electrostatically complexed with surface functionalized gold nanorods (GNRs). Notably, the RNA polynucleotides are not covalently bound to the GNRs. The method involves administering an effective amount of a composition containing these complexes to an individual, thereby inhibiting the expression of a target gene.
Career Highlights
Adela Bonoiu's career is marked by her dedication to advancing scientific knowledge and technology. She is affiliated with the State University of New York, where she continues her research and development in the field of biotechnology. Her work has the potential to impact various applications in medicine and genetic research.
Collaborations
Adela collaborates with esteemed colleagues, including Earl Jim Bergey and Supriya Mahajan. These partnerships enhance her research efforts and contribute to the advancement of innovative solutions in biotechnology.
Conclusion
Adela Bonoiu is a trailblazer in the field of RNA interference technology, with a focus on utilizing gold nanorods for gene expression inhibition. Her contributions are paving the way for future advancements in biotechnology and medicine.